• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

NIH: Asthma flare-ups not prevented by temporary increases to inhaled steroid dose

March 5, 2018 By Sarah Faulkner

asthma inhalerTemporarily increasing the amount of inhaled steroids that young children take when their asthma symptoms worsen does not prevent severe flare-ups, according to a new study from the National Institutes of Health.

The findings buck traditional medical practice involving kids with mild-to-moderate asthma. Asthma flare-ups are common among children with asthma and most doctors recommend boosting a patient’s dose of inhaled steroids from low to high at the first sign of coughing and wheezing.

“These findings suggest that a short-term increase to high-dose inhaled steroids should not be routinely included in asthma treatment plans for children with mild-moderate asthma who are regularly using low-dose inhaled corticosteroids,” study leader Dr. Daniel Jackson said in prepared remarks. “Low-dose inhaled steroids remain the cornerstone of daily treatment in affected children.”

The researchers evaluated 254 kids, ages 5 to 11, over the course of one year. All of the participants were given two puffs from an inhaler twice per day. At the first signs of a flare-up, researchers continued giving low-dose inhaled steroids to half of the kids and switched to high-dose inhaled steroids for the other half of the kids, two times per day for seven days during each flare-up episode.

The kids in the high-dose group experienced similar asthma symptoms compared to the kids in the low-dose group, according to the researchers, and had a similar length of time until the first severe flare-up.

The researchers also noted that children in the short-term high-dose group grew at a lesser rate than those in the low-dose group. The growth difference was small, but the team said the finding is consistent with previous studies.

“This study allows caregivers to make informed decisions about how to treat their young patients with asthma,” James Kiley, director of the National Heart, Lung and Blood Institute’s lung disease division, said. “Trials like this can be used in the development of treatment guidelines for children with asthma.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Research & Development Tagged With: National Institutes of Health

IN CASE YOU MISSED IT

  • Omnipod 5 rollout for type 2 rolls on as Insulet pursues next-gen automation
  • LifePlus reports clinical validation of non-invasive glucose, blood pressure monitor
  • Abbott Diabetes head talks Medtronic partnership, exciting times ahead
  • PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
  • Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS